RxDoctor Payments Data

Rebecca Hardy, PA

Physician Assistant · Louisville, KYNPI 1568891406

Payments from drug & device makers

$1,464in general payments, 2019–2025

Across 63 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$317
  • Sanofi$235
  • Amneal Pharmaceuticals LLC$212
  • Optinose US, Inc.$169
  • Medtronic$139
  • Lucid Diagnostics Inc.$117
  • plus $276 from 6 others

What the payments were for

  • Food & beverage$1,40896%
  • Education$564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,464 in reported general payments places this provider in the 70th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$95,808
Medicare patients
468
Services billed
1,288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynthroidLevothyroxine Sodium224$18,050
TirosintLevothyroxine Sodium43$10,477
Liothyronine Sodium121$5,364
Levothyroxine Sodium224$3,272
Fluticasone Propionate162$2,240
Np ThyroidThyroid,pork49$2,136
Azelastine Hcl86$1,896
Ipratropium Bromide23$983
LevoxylLevothyroxine Sodium40$856
UnithroidLevothyroxine Sodium44$741
Calcitriol17$474
Montelukast Sodium49$431
Levocetirizine Dihydrochloride18$356
Ciprofloxacin Hcl20$326
Omeprazole48$251

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$66$18,050224 claims
IBSA Pharma Inc.Tirosint$111$10,47743 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$212$4,012268 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →